 SOUTH SAN FRANCISCO, Calif., Aug. 30, 2022 GLOBE NEWSWIRE -- Pliant Therapeutics, Inc. Nasdaq: PLRX, a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer, and members of Pliants senior management will participate in the following September investor conferences: 